Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Medical Hypotheses|November 9, 2015
Involvement of steatosis-induced glucagon resistance in hyperglucagonaemiaMalte P Suppli, Asger Lund, Jonatan I Bagger, et al.
Peptides|April 24, 2024
Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humansAnders Englund, Hannah Gilliam-Vigh, Malte P Suppli, et al.
Nutrients|February 26, 2025
Cholesin mRNA Expression in Human Intestinal, Liver, and Adipose TissuesHannah Gilliam-Vigh, Malte P Suppli, Sebastian M N Heimbürger, et al.
European Journal of Endocrinology|August 9, 2021
MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatinMads R Andersen, Malte P Suppli, Jonatan I Bagger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 7, 2019
Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversionPeter Lykke Eriksen, Hendrik Vilstrup, Kristoffer Rigbolt, et al.
Physiological Reviews|July 28, 2025
Proglucagon-derived Peptides: Human Physiology and Therapeutic PotentialLærke S Gasbjerg, Casper K Nielsen, Malte P Suppli, et al.
Endocrine Connections|November 10, 2023
Hyperglucagonaemia and amino acid alterations in individuals with type 2 diabetes and non-alcoholic fatty liver diseaseIben Rix, Marie L Johansen, Asger Lund, et al.
Endocrine Reviews|March 29, 2019
The Liver-α-Cell Axis and Type 2 DiabetesNicolai J Wewer Albrechtsen, Jens Pedersen, Katrine D Galsgaard, et al.
Diabetes|June 3, 2022
The Liver-α-Cell Axis in Health and in DiseaseMichael M Richter, Katrine D Galsgaard, Emilie Elmelund, et al.
Metabolic Syndrome and Related Disorders|October 17, 2018
Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control SubjectsMia Demant, Jonatan I Bagger, Malte P Suppli, et al.
Pageof 2